6 High resolution melting: a useful field-deployable method to measure dhfr and dhps drug resistance in both highly and lowly endemic Plasmodium populations.

7 Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061).

8 Synthesis of Novel 1,2,3-Triazole Derivatives of Isocoumarins and 3,4-Dihydroisocoumarin with Potential Antiplasmodial Activity In Vitro.

9 Total Synthesis and Antimalarial Activity of Dominicin, a Cyclic Octapeptide from a Marine Sponge.

10 The multifaceted histone chaperone RbAp46/48 in Plasmodium falciparum: structural insights, production, and characterization.

11 Characterization and genome sequencing of three Aeromonas hydrophila-specific phages, CF8, PS1, and PS2.

12 anti-protozoal activities of cembrane-type diterpenes from vietnamese soft corals

13 strategies for designing and monitoring malaria vaccines targeting diverse antigens

14 a gbp 130 derived peptide from plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro

15 epidemiology of malaria and chloroquine resistance in mizoram, northeastern india, a malaria-endemic region bordering myanmar

16 loop myopexy with true muscle transplantation for very large angle heavy eye syndrome patient

17 drug susceptibility of plasmodium falciparum in the western amazon region, state of acre, brazil susceptibilidade a droga, do plasmodium falciparum, na amazônia ocidental, estado do acre, brasil

18 chemoresistance of plasmodium falciparum and plasmodium vivax parasites in brazil: consequences on disease morbidity and control

19 the search for new antimalarial drugs from plants used to treat fever and malaria or plants ramdomly selected: a review

20 chloroquine sensitivity of plasmodium falciparum in berakit, bintan island, sumatra, after mass chemoprophylaxis through community participation, and its sociological studies

21 mutations in plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the amazon region of brazil

22 synthesis and antimalarial evaluation of cyclic ÃŽÂ²-amino acid-containing dipeptides

23 high sporozoite antibody titers in conjunction with microscopically detectable blood infection display signatures of protection from clinical malaria

24 mutaciones puntuales en los genes dhfr y dhps de plasmodium falciparum de tres regiones endémicas

25 synthesis and antiplasmodial evaluation of analogues based on the tricyclic core of thiaplakortones a–d

26 in-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant plasmodium falciparum.

27 synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-plasmodium falciparum agents

28 gametocitemia en malaria por plasmodium falciparum tratada con amodiaquina o artesunato

29 seroepidemiologic assessment of malaria using an elisa for ring-infected erythrocyte surface antigen of plasmodium falciparum

30 eficacia terapéutica de tres esquemas de tratamiento de malaria no complicada por plasmodium falciparum, antioquia, colombia, 2002.

31 in vitro antiplasmodial activity of phospholipases a2 and a phospholipase homologue isolated from the venom of the snake bothrops asper

32 structure of the knob protein gene of the saimiri monkey-adapted palo alto strain of plasmodium falciparum

33 pfcrt and pfmdr1 alleles associated with chloroquine resistance in plasmodium falciparum from guyana, south america

34 treatment of severe malaria

35 identificación de un epítope conformacional en el extremo carboxilo de la proteína msp-1 de p. falciparum

36 revista de tesis de la facultad de medicina de bogotá

37 a unique subset of γδ t cells expands and produces il-10 in patients with naturally acquired immunity against falciparum malaria

38 several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, as new anti-malarial agents

39 plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies

40 malária falciparum resistente à cloroquina e ao fansidar r tratada com minociclina minocycline treatment of chloroquine-and fansidar r-resistant falciparum malarial

41 In Silico Prediction of Cytoadherence Inhibitors That Disrupt Interaction between gC1qR-DBLβ12 Complex.

42 Plasmodium falciparum PFI1625c offers an opportunity to design potent anti-malarials: Biochemical characterization and testing potentials in drug discovery.

43 The search for plasmodium falciparum histidine-rich protein 2/3 deletions in Zambia and implications for plasmodium falciparum histidine-rich protein 2-based rapid diagnostic tests

44 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

45 Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia

46 Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014

47 Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname

48 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

49 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

50 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

51 Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia

52 Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014

53 Multiple-Strain Malaria Infection and Its Impacts on Plasmodium falciparum Resistance to Antimalarial Therapy: A Mathematical Modelling Perspective

54 Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname

55 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

56 Socioeconomic Risk Factors for <i>Plasmodium falciparum</i> Infection in Primary School Children in Three Districts of the Volta Region Of Ghana.

57 Correction: Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

58 Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

59 Extracellular vesicles carrying lactate dehydrogenase induce suicide in increased population density of Plasmodium falciparum in vitro

60 Characterization of the accessible genome in the human malaria parasite Plasmodium falciparum.

61 Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.

62 Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.

63 Pregnant Women: An Overlooked Asset to Plasmodium falciparum Malaria Elimination Campaigns?

64 Adaptation of Plasmodium falciparum to humans involved the loss of an ape-specific erythrocyte invasion ligand.

65 Assessment of the Combined Effect of Epstein–Barr Virus and Plasmodium falciparum Infections on Endemic Burkitt Lymphoma Using a Multiplex Serological Approach

66 Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity.

67 Infants' Peripheral Blood Lymphocyte Composition Reflects Both Maternal and Post-Natal Infection with Plasmodium falciparum.

68 Synthesis and anti-Plasmodium falciparum evaluation of novel pyrazolopyrimidine derivatives

69 Pan-Plasmodium band sensitivity for Plasmodium falciparum detection in combination malaria rapid diagnostic tests and implications for clinical management.

70 Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda.

71 Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection.

72 Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.

73 Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for <it>Plasmodium falciparum </it>malaria in a hyperendemic region of Uganda

74 Stabilization of chloroquine resistance in vivo of plasmodium falciparum in edea, south cameroon

75 Increase of chloroquine resistance in vivo of plasmodium falciparum over two years in edea, South Cameroon

76 In vivo study of amodiaquine sensitivity of Plasmodium falciparum in the town of Edea (Cameroon)

77 An Exported Heat Shock Protein 40 Associates with Pathogenesis-Related Knobs in Plasmodium falciparum Infected Erythrocytes

78 Prevalence of afebrile parasitaemia due to Plasmodium falciparum & P. vivax in district Balaghat (Madhya Pradesh): Implication for malaria control

79 Plasma cytokines, chemokines and cellular immune responses in pre-school Nigerian children infected with <it>Plasmodium falciparum</it>

80 Assessment of Antimalarial Activity against Plasmodium falciparum and Phytochemical Screening of Some Yemeni Medicinal Plants

81 Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.

82 Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum

83 Synthesis of new 4-Aminoquinolines and evaluation of their in vitro activity against chloroquine-sensitive and chloroquine-resistant plasmodium falciparum

84 Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum

85 The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection

86 Plasmodium falciparum and Helminth Coinfection in a Semiurban Population of Pregnant Women in Uganda

87 Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia

88 Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children

89 Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria

90 Out of Africa: origins and evolution of the human malaria parasites Plasmodium falciparum and Plasmodium vivax

91 Loss of cellular immune reactivity during acute Plasmodium falciparum malaria

92 Use of Peroxisome Proliferator-Activated Receptor γ Agonists as Adjunctive Treatment for Plasmodium falciparum Malaria: A Randomized, Double-Blind, Placebo-Controlled Trial

93 Antigen-Specific Immunosuppression in Human Malaria Due to Plasmodium falciparum

94 Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire

95 Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum

96 Plasmodium falciparum and helminth co-infection in a semi-urban population of pregnant women in Uganda

97 Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome

98 Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria

99 Plasmodium falciparum and helminth coinfection in a semi urban population of pregnant women in Uganda

100 assessment of clinical diagnosis, microscopy, rapid diagnostic tests, and polymerase chain reaction in the diagnosis of plasmodium falciparum in nigeria

101 delayed cerebellar ataxia: a rare self limiting complication of plasmodium falciparum malaria

Keyword Connections

Journals

Research Groups

Bibliographies